<\/p>\n
Momin Cream<\/strong> is a topical 0.1% mometasone furoate cream from Cipla — a potent topical corticosteroid (UK Class III \/ US Class III-II)<\/strong> used for short-term treatment of steroid-responsive inflammatory skin conditions including eczema (atopic dermatitis), psoriasis vulgaris, contact dermatitis, lichen planus, discoid lupus, seborrhoeic dermatitis of the scalp\/body<\/strong>, and other dermatoses. Apply a thin film once daily<\/strong> to affected areas; mometasone’s once-daily dosing is a key advantage over most other potent steroids. Maximum course 2–4 weeks on the body<\/strong> \u03ba\u03b1\u03b9 5–7 days only on the face<\/strong>. Do NOT use on rosacea, acne, perioral dermatitis, broken skin, or untreated skin infection — mometasone worsens<\/strong> these conditions.<\/p>\n<\/div>\n \ud83d\udce6 \u039a\u03ac\u03b8\u03b5 \u03c0\u03b1\u03c1\u03b1\u03b3\u03b3\u03b5\u03bb\u03af\u03b1 \u03ba\u03b1\u03bb\u03cd\u03c0\u03c4\u03b5\u03c4\u03b1\u03b9 \u03b1\u03c0\u03cc \u03c4\u03b7\u03bd \u03a0\u03bf\u03bb\u03b9\u03c4\u03b9\u03ba\u03ae \u0395\u03b3\u03b3\u03cd\u03b7\u03c3\u03b7\u03c2 \u0395\u03c0\u03b1\u03bd\u03b1\u03c0\u03bf\u03c3\u03c4\u03bf\u03bb\u03ae\u03c2<\/strong><\/a> \u2014 \u03b5\u03ac\u03bd \u03c4\u03bf \u03b4\u03ad\u03bc\u03b1 \u03c3\u03b1\u03c2 \u03b4\u03b5\u03bd \u03c6\u03c4\u03ac\u03c3\u03b5\u03b9 \u03b5\u03bd\u03c4\u03cc\u03c2 20 \u03b5\u03c1\u03b3\u03ac\u03c3\u03b9\u03bc\u03c9\u03bd \u03b7\u03bc\u03b5\u03c1\u03ce\u03bd, \u03c4\u03bf \u03b5\u03c0\u03b1\u03bd\u03b1\u03c0\u03bf\u03c3\u03c4\u03ad\u03bb\u03bb\u03bf\u03c5\u03bc\u03b5.<\/p>\n \u03a4\u03b1 \u03b3\u03b5\u03bd\u03cc\u03c3\u03b7\u03bc\u03b1 \u03c6\u03ac\u03c1\u03bc\u03b1\u03ba\u03ac \u03bc\u03b1\u03c2 \u03c0\u03c1\u03bf\u03ad\u03c1\u03c7\u03bf\u03bd\u03c4\u03b1\u03b9 \u03b1\u03c0\u03cc \u03ba\u03b1\u03c4\u03b1\u03c3\u03ba\u03b5\u03c5\u03b1\u03c3\u03c4\u03ad\u03c2 \u03c0\u03bf\u03c5 \u03c0\u03b9\u03c3\u03c4\u03bf\u03c0\u03bf\u03b9\u03bf\u03cd\u03bd\u03c4\u03b1\u03b9 \u03b1\u03c0\u03cc \u03c4\u03b7\u03bd WHO-GMP \u03ba\u03b1\u03b9 \u03b1\u03c0\u03bf\u03c3\u03c4\u03ad\u03bb\u03bb\u03bf\u03bd\u03c4\u03b1\u03b9 \u03c0\u03b1\u03b3\u03ba\u03bf\u03c3\u03bc\u03af\u03c9\u03c2 \u03c3\u03b5 \u03b4\u03b9\u03b1\u03ba\u03c1\u03b9\u03c4\u03b9\u03ba\u03ae, \u03b1\u03c0\u03bb\u03ae \u03c3\u03c5\u03c3\u03ba\u03b5\u03c5\u03b1\u03c3\u03af\u03b1 \u2014 \u03c7\u03c9\u03c1\u03af\u03c2 \u03cc\u03bd\u03bf\u03bc\u03b1 \u03c6\u03b1\u03c1\u03bc\u03ac\u03ba\u03bf\u03c5 \u03c3\u03c4\u03bf \u03b5\u03be\u03c9\u03c4\u03b5\u03c1\u03b9\u03ba\u03cc \u03c4\u03bf\u03c5 \u03b4\u03ad\u03bc\u03b1\u03c4\u03bf\u03c2. \u039f\u03b9 \u03c0\u03bb\u03b7\u03c1\u03c9\u03bc\u03ad\u03c2 \u03bc\u03b5 \u03ba\u03ac\u03c1\u03c4\u03b1 \u03b4\u03c1\u03bf\u03bc\u03bf\u03bb\u03bf\u03b3\u03bf\u03cd\u03bd\u03c4\u03b1\u03b9 \u03bc\u03ad\u03c3\u03c9 \u03c1\u03c5\u03b8\u03bc\u03b9\u03c3\u03bc\u03ad\u03bd\u03bf\u03c5 \u03b5\u03c0\u03b5\u03be\u03b5\u03c1\u03b3\u03b1\u03c3\u03c4\u03ae (\u03bf\u03b9 \u03c0\u03b5\u03c1\u03b9\u03b3\u03c1\u03b1\u03c6\u03ad\u03c2 \u03b5\u03ba\u03ba\u03b1\u03b8\u03ac\u03c1\u03b9\u03c3\u03b7\u03c2 \u03c0\u03b5\u03c1\u03b9\u03bb\u03b1\u03bc\u03b2\u03ac\u03bd\u03bf\u03c5\u03bd \u03c1\u03c5\u03b8\u03bc\u03b9\u03c3\u03bc\u03ad\u03bd\u03bf \u03b5\u03c0\u03b5\u03be\u03b5\u03c1\u03b3\u03b1\u03c3\u03c4\u03ae \u03c0\u03bb\u03b7\u03c1\u03c9\u03bc\u03ce\u03bd \u03bc\u03b5 \u03ba\u03ac\u03c1\u03c4\u03b1 \u2014 \u03c0\u03bf\u03c4\u03ad \u201cMedsBase\u201d \u03ae \u03bf\u03c0\u03bf\u03b9\u03bf\u03b4\u03ae\u03c0\u03bf\u03c4\u03b5 \u03cc\u03bd\u03bf\u03bc\u03b1 \u03c6\u03b1\u03c1\u03bc\u03ac\u03ba\u03bf\u03c5). \u0393\u03af\u03bd\u03bf\u03bd\u03c4\u03b1\u03b9 \u03b4\u03b5\u03ba\u03c4\u03ad\u03c2 \u03ba\u03b1\u03b9 \u03c0\u03bb\u03b7\u03c1\u03c9\u03bc\u03ad\u03c2 \u03bc\u03b5 \u03ba\u03c1\u03c5\u03c0\u03c4\u03bf\u03bd\u03bf\u03bc\u03af\u03c3\u03bc\u03b1\u03c4\u03b1 \u03ba\u03b1\u03b9 \u03c4\u03c1\u03b1\u03c0\u03b5\u03b6\u03b9\u03ba\u03ae \u03bc\u03b5\u03c4\u03b1\u03c6\u03bf\u03c1\u03ac SEPA. \u039a\u03ac\u03b8\u03b5 \u03c0\u03b1\u03c1\u03b1\u03b3\u03b3\u03b5\u03bb\u03af\u03b1 \u03ba\u03b1\u03bb\u03cd\u03c0\u03c4\u03b5\u03c4\u03b1\u03b9 \u03b1\u03c0\u03cc \u03c4\u03b7\u03bd \u03a0\u03bf\u03bb\u03b9\u03c4\u03b9\u03ba\u03ae \u0395\u03c0\u03b1\u03bd\u03b1\u03c0\u03bf\u03c3\u03c4\u03bf\u03bb\u03ae\u03c2 \u0395\u03be\u03b1\u03c3\u03c6\u03b1\u03bb\u03af\u03c3\u03b5\u03ce\u03c2 \u03bc\u03b1\u03c2.<\/p>\n Momin Cream is Cipla’s generic 0.1% mometasone furoate cream \u2014 pharmacologically equivalent to Elocon (the original MSD brand) and to every other 0.1% mometasone topical.<\/p>\n Momin Cream is a 0.1% mometasone furoate<\/strong> topical cream, manufactured by Cipla and supplied in a 15 g tube. Mometasone furoate is a synthetic glucocorticoid (corticosteroid) classified as a potent topical steroid<\/strong> (UK Class III). It was specifically engineered for topical use — its metabolism by skin esterases to inactive metabolites means systemic absorption after topical application is low<\/strong>, giving it one of the best therapeutic windows of any potent topical corticosteroid.<\/p>\n Mometasone binds intracellular glucocorticoid receptors in keratinocytes, dermal fibroblasts, and infiltrating inflammatory cells. The activated receptor suppresses transcription of pro-inflammatory cytokines (IL-1, IL-2, IL-6, TNF-α), inhibits phospholipase A2<\/sub>, and promotes apoptosis of T-lymphocytes infiltrating the inflamed skin. The result is rapid suppression of the inflammatory cascade driving eczema and psoriasis flares.<\/p>\n Onset: 24–48 hours for itch and redness; full response at 1–2 weeks.<\/p>\n Topical steroid dosing uses the fingertip unit (FTU)<\/strong>: the amount squeezed from a 5 mm-nozzle tube along an adult index finger from tip to first crease. 1 FTU ≈ 0.5 g<\/strong> treats an area about the size of two adult palms.<\/p>\n FTU per adult body region:<\/strong><\/p>\n Application steps:<\/strong><\/p>\n Local (more common with prolonged use, occlusion, or thin-skin sites):<\/strong><\/p>\n Systemic (rare at recommended dose; real risk with high-dose, large-area, prolonged, or occlusive use):<\/strong> HPA-axis suppression, iatrogenic Cushing’s syndrome, hyperglycaemia, glaucoma\/cataract from periocular use, growth suppression in children.<\/p>\n Stopping a potent topical steroid abruptly after more than 2–3 weeks of daily use commonly triggers a rebound flare<\/strong> — original eczema or psoriasis returns, often worse than baseline, sometimes with burning or topical steroid withdrawal syndrome (TSWS).<\/p>\n Step-down strategies used in dermatology:<\/p>\n \u0395\u03b3\u03ba\u03c5\u03bc\u03bf\u03c3\u03cd\u03bd\u03b7:<\/strong> avoid extensive or prolonged use. Brief use over small area for essential indication is generally considered acceptable. High cumulative topical-steroid exposure in pregnancy has been associated with low birth weight.<\/p>\n Store below 25°C. Replace cap tightly after each use. Keep out of reach of children. Use within 3–6 months of opening or before the expiry date, whichever is sooner.<\/p>\n \u038c\u03c7\u03b9.<\/strong> Mometasone (like all potent topical steroids) can trigger or worsen \u03c3\u03c4\u03b5\u03c1\u03b5\u03b9\u03b4\u03bf\u03b3\u03b5\u03bd\u03ae \u03c1\u03bf\u03b4\u03cc\u03c7\u03c1\u03c9\u03c3\u03b7<\/em> — persistent redness, telangiectasia, papules and pustules appearing after days to weeks of facial steroid use. If you have rosacea, use topical ivermectin 1% (Ivrea Cream)<\/a>, azelaic acid (Aziderm)<\/a>, \u03ae brimonidine gel (Erythego)<\/a> — the evidence-based rosacea topicals.<\/p>\n Relief of itch and redness within 24–48 hours. Full response in 1–2 weeks for eczema; psoriasis plaques may take 2–4 weeks for meaningful thinning. If no improvement at 2 weeks, stop and review the diagnosis — fungal infection mistaken for eczema is the most common reason.<\/p>\n Facial skin is thinner and more permeable than body skin, so systemic absorption is 6–15× higher from the face. The risk of perioral dermatitis, steroid-induced rosacea, telangiectasia, and irreversible atrophy rises steeply beyond 1 week of facial use. For facial inflammation, a mild steroid (hydrocortisone 1%) or a topical calcineurin inhibitor (tacrolimus, pimecrolimus) is the appropriate choice.<\/p>\n No — occlusion multiplies systemic absorption up to ten-fold and dramatically raises the risk of atrophy and HPA-axis suppression. Occluded steroid therapy is a specialised dermatology technique used only under direct supervision.<\/p>\n Children have more permeable skin and higher risk of growth suppression and HPA-axis effects from potent topical steroids. Generally not for under 2 years. In ages 2–12, used only under paediatric dermatology supervision — preferred starting agents are mild steroids (hydrocortisone 1%) or topical calcineurin inhibitors (tacrolimus 0.03%).<\/p>\n Classic steroid rebound flare<\/strong> from abrupt discontinuation. Restart, then plan a tapered step-down — moderate-potency steroid for 1–2 weeks, then mild, then emollient ± topical calcineurin inhibitor for long-term maintenance.<\/p>\n Avoid extensive or prolonged use. Brief use over a small area for an essential flare is generally considered acceptable. High cumulative topical-steroid exposure during pregnancy has been associated with low birth weight in some studies. Discuss with your obstetrician.<\/p>\n You can buy Momin Cream (mometasone 0.1% cream, 15 g tube) from MedsBase with discreet packaging and worldwide shipping.<\/p>\n <\/p>\n \u0386\u03bb\u03bb\u03b1 \u03c0\u03c1\u03bf\u03ca\u03cc\u03bd\u03c4\u03b1 \u03c3\u03b5 \u03a7\u03c1\u03cc\u03bd\u03b9\u03b5\u03c2 \u03a0\u03b1\u03b8\u03ae\u03c3\u03b5\u03b9\u03c2<\/strong> \u03c0\u03bf\u03c5 \u03bf\u03b9 \u03c0\u03b5\u03bb\u03ac\u03c4\u03b5\u03c2 \u03b5\u03be\u03b5\u03c4\u03ac\u03b6\u03bf\u03c5\u03bd \u03b5\u03c0\u03af\u03c3\u03b7\u03c2:<\/p>\n Momin Cream is Cipla’s 0.1% mometasone furoate topical cream \u2014 a potent once-daily topical corticosteroid (UK Class III) for eczema (atopic dermatitis), psoriasis, contact dermatitis, lichen planus, discoid lupus, and other steroid-responsive dermatoses. Apply thin film once daily for up to 2\u20134 weeks on body sites; max 5\u20137 days on face. Not for rosacea, acne, or perioral dermatitis.<\/p>","protected":false},"featured_media":59241,"comment_status":"open","ping_status":"open","template":"","meta":[],"product_brand":[],"product_cat":[3141,3223,3563],"product_tag":[4653,4656],"class_list":{"0":"post-59240","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-category-overview","7":"product_cat-chronic-conditions","8":"product_cat-rosacea-treatment","9":"product_tag-momentasone","10":"product_tag-momin-cream","12":"first","13":"instock","14":"shipping-taxable","15":"purchasable","16":"product-type-variable","17":"has-default-attributes"},"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/el\/wp-json\/wp\/v2\/product\/59240","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/el\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/el\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/el\/wp-json\/wp\/v2\/comments?post=59240"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/el\/wp-json\/wp\/v2\/media\/59241"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/el\/wp-json\/wp\/v2\/media?parent=59240"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/el\/wp-json\/wp\/v2\/product_brand?post=59240"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/el\/wp-json\/wp\/v2\/product_cat?post=59240"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/el\/wp-json\/wp\/v2\/product_tag?post=59240"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}\u0393\u03b9\u03b1\u03c4\u03af \u03bd\u03b1 \u03c0\u03b1\u03c1\u03b1\u03b3\u03b3\u03b5\u03af\u03bb\u03b5\u03c4\u03b5 \u03b1\u03c0\u03cc \u03c4\u03b7 MedsBase<\/h3>\n
What Is Momin Cream?<\/h2>\n
How Momin Cream Works<\/h2>\n
\u0395\u03b3\u03ba\u03b5\u03ba\u03c1\u03b9\u03bc\u03ad\u03bd\u03b5\u03c2 \u03a7\u03c1\u03ae\u03c3\u03b5\u03b9\u03c2<\/h2>\n
\n
Momin Cream Dosage — the Fingertip Unit Rule<\/h2>\n
\n
\n
Where NOT to Apply Momin Cream<\/h2>\n
\n
\u03a0\u03b1\u03c1\u03b5\u03bd\u03ad\u03c1\u03b3\u03b5\u03b9\u03b5\u03c2 & \u0391\u03c3\u03c6\u03ac\u03bb\u03b5\u03b9\u03b1<\/h2>\n
\n
How to Stop Momin Cream — Avoiding Rebound<\/h2>\n
\n
Contraindications & Pregnancy<\/h2>\n
\n
\u0391\u03c0\u03bf\u03b8\u03ae\u03ba\u03b5\u03c5\u03c3\u03b7<\/h2>\n
\u03a3\u03c5\u03c7\u03bd\u03ad\u03c2 \u0395\u03c1\u03c9\u03c4\u03ae\u03c3\u03b5\u03b9\u03c2<\/h2>\n
Can I use Momin Cream for rosacea?<\/h3>\n
How long does Momin Cream take to work?<\/h3>\n
Why is the face limit only 5–7 days?<\/h3>\n
Can I cover Momin Cream with a bandage?<\/h3>\n
Can children use Momin Cream?<\/h3>\n
My eczema came back worse when I stopped — why?<\/h3>\n
Is Momin Cream safe in pregnancy?<\/h3>\n
Where can I buy Momin Cream online?<\/h3>\n
Related Treatments on MedsBase<\/h2>\n
\n
\u03a3\u03c7\u03b5\u03c4\u03b9\u03ba\u03ad\u03c2 \u0395\u03bd\u03b1\u03bb\u03bb\u03b1\u03ba\u03c4\u03b9\u03ba\u03ad\u03c2<\/h3>\n
\n